OS Therapies Agrees to Acquire All Listeria Monotygenes-based Immuno-Oncology Programs and IP Assets from Ayala Pharmaceuticals, Adding Phase 2 Lung Cancer and Phase 1 Prostate Cancer Programs to Pipeline
January 29, 2025
CEO Adam Levy educates us on the use of energy from their electron beam accelerator to crosslink water and polymers into beautifying sheets of water.
January 29, 2025
January 14, 2025
July 16, 2024
July 9, 2024